Literature DB >> 17110046

Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease.

M P Smith1, W A Cass.   

Abstract

Although the etiology of Parkinson's disease (PD) is unknown, a common element of most theories is the involvement of oxidative stress, either as a cause or effect of the disease. There have been relatively few studies that have characterized oxidative stress in animal models of PD. In the present study a 6-hydroxydopamine (6-OHDA) rodent model of PD was used to investigate the in vivo production of oxidative stress after administration of the neurotoxin. 6-OHDA was injected into the striatum of young adult rats and the production of protein carbonyls and 4-hydroxynonenal (HNE) was measured at 1, 3, 7, and 14 days after administration. A significant increase in both markers was found in the striatum 1 day after neurotoxin administration, and this increase declined to basal levels by day 7. There was no significant increase found in the substantia nigra at any of the time points investigated. This same lesion paradigm produced dopamine depletions of 90-95% in the striatum and 63-80% in the substantia nigra by 14-28 days post-6-OHDA. Protein carbonyl and HNE levels were also measured in middle-aged and aged animals 1 day after striatal 6-OHDA. Both protein carbonyl and HNE levels were increased in the striatum of middle-aged and aged animals treated with 6-OHDA, but the increases were not as great as those observed in the young adult animals. Similar to the young animals, there were no increases in either marker in the substantia nigra of the middle-aged and aged animals. There was a trend for an age-dependent increase in basal amounts of oxidative stress markers when comparing the non-lesioned side of the brains of the three age groups. These results support that an early event in the course of dopamine depletion following intrastriatal 6-OHDA administration is the generation of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17110046      PMCID: PMC2048571          DOI: 10.1016/j.neuroscience.2006.10.004

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  61 in total

1.  Measurements of protein carbonyls, ortho- and meta-tyrosine and oxidative phosphorylation complex activity in mitochondria from young and old rats.

Authors:  S M Davies; A Poljak; M W Duncan; G A Smythe; M P Murphy
Journal:  Free Radic Biol Med       Date:  2001-07-15       Impact factor: 7.376

2.  Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats.

Authors:  Wayne A Cass; Michael E Harned; Sherry L Bailey
Journal:  Brain Res       Date:  2002-05-31       Impact factor: 3.252

3.  Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat.

Authors:  Maria J Martí; Josep Saura; Robert E Burke; Vernice Jackson-Lewis; Anna Jiménez; Mercé Bonastre; Eduard Tolosa
Journal:  Brain Res       Date:  2002-12-20       Impact factor: 3.252

Review 4.  Importance of individuality in oxidative stress and aging.

Authors:  Earl R Stadtman
Journal:  Free Radic Biol Med       Date:  2002-09-01       Impact factor: 7.376

5.  Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage.

Authors:  Jimin Wu; Ya Hua; Richard F Keep; Timothy Schallert; Julian T Hoff; Guohua Xi
Journal:  Brain Res       Date:  2002-10-25       Impact factor: 3.252

6.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

Review 7.  Animal models of Parkinson's disease.

Authors:  Ranjita Betarbet; Todd B Sherer; J Timothy Greenamyre
Journal:  Bioessays       Date:  2002-04       Impact factor: 4.345

8.  Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.

Authors:  Ramón Soto-Otero; Estefanía Méndez-Alvarez; Alvaro Hermida-Ameijeiras; Ana María López-Real; José Luis Labandeira-García
Journal:  Biochem Pharmacol       Date:  2002-07-01       Impact factor: 5.858

9.  Induced expression of early response genes/oxidative injury in rat pheochromocytoma (PC12) cell line by 6-hydroxydopamine: implication for Parkinson's disease.

Authors:  K Seth; A K Agrawal; M H Aziz; A Ahmad; Y Shukla; N Mathur; P K Seth
Journal:  Neurosci Lett       Date:  2002-09-13       Impact factor: 3.046

Review 10.  Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.

Authors:  Ronald Deumens; Arjan Blokland; Jos Prickaerts
Journal:  Exp Neurol       Date:  2002-06       Impact factor: 5.330

View more
  20 in total

1.  Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.

Authors:  Wayne A Cass; Laura E Peters
Journal:  Neurochem Int       Date:  2010-07-06       Impact factor: 3.921

2.  L-DOPA reverses motor deficits associated with normal aging in mice.

Authors:  Erika Allen; Kirsten M Carlson; Michael J Zigmond; Jane E Cavanaugh
Journal:  Neurosci Lett       Date:  2010-11-25       Impact factor: 3.046

3.  Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion.

Authors:  Rebecca L Cunningham; Teresa Macheda; Lora Talley Watts; Ethan Poteet; Meharvan Singh; James L Roberts; Andrea Giuffrida
Journal:  Horm Behav       Date:  2011-08-31       Impact factor: 3.587

4.  Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss.

Authors:  A L Spieles-Engemann; M M Behbehani; T J Collier; S L Wohlgenant; K Steece-Collier; K Paumier; B F Daley; S Gombash; L Madhavan; G T Mandybur; J W Lipton; B T Terpstra; C E Sortwell
Journal:  Neurobiol Dis       Date:  2010-03-20       Impact factor: 5.996

5.  GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  Michael P Smith; Wayne A Cass
Journal:  Neurosci Lett       Date:  2006-11-27       Impact factor: 3.046

6.  Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.

Authors:  Gregory C Hadlock; Anthony J Baucum; Jill L King; Kristen A Horner; Glen A Cook; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

7.  Bilirubin and glutathione have complementary antioxidant and cytoprotective roles.

Authors:  Thomas W Sedlak; Masoumeh Saleh; Daniel S Higginson; Bindu D Paul; Krishna R Juluri; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-13       Impact factor: 11.205

8.  Nanoparticles induce changes of the electrical activity of neuronal networks on microelectrode array neurochips.

Authors:  Alexandra Gramowski; Juliane Flossdorf; Kunal Bhattacharya; Ludwig Jonas; Margareta Lantow; Qamar Rahman; Dietmar Schiffmann; Dieter G Weiss; Elke Dopp
Journal:  Environ Health Perspect       Date:  2010-05-10       Impact factor: 9.031

9.  Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses.

Authors:  Andrea Haase; Stephanie Rott; Alexandre Mantion; Philipp Graf; Johanna Plendl; Andreas F Thünemann; Wolfgang P Meier; Andreas Taubert; Andreas Luch; Georg Reiser
Journal:  Toxicol Sci       Date:  2012-01-12       Impact factor: 4.849

Review 10.  Oxidative stress in genetic mouse models of Parkinson's disease.

Authors:  Mustafa Varçin; Eduard Bentea; Yvette Michotte; Sophie Sarre
Journal:  Oxid Med Cell Longev       Date:  2012-07-08       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.